Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients. Effect of subcutaneous erythropoietin replacement therapy.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Clinical and experimental hypertension

• Publication date

  1994-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10641969409067962PMID 7951163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin.

  1993cited by this paper
• Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.

  1993cited by this paper
• Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells.

  1993cited by this paper
• Plasma Immunoreactive Endothelin Levels Are Increased in Hemodialysis Patients with Hypertension Following Erythropoietin Therapy

  1992cited by this paper
• Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.

  1992cited by this paper
• Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin.

  1991cited by this paper
• Regulatory functions of the vascular endothelium.

  1990cited by this paper
• Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.

  1990cited by this paper
• Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.

  1989cited by this paper
• Plasma endothelin levels in patients with uraemia.

  1989cited by this paper
• Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients.

  1989cited by this paper
• Theoretical and practical implications of continuous ambulatory peritoneal dialysis.

  1978cited by this paper

• Impact of prolonged duration of different types of renal replacement therapies on serum levels of endothelin-1 and pulmonary function tests.

  2021cites this paper
• Mechanisms and mediators of hypertension induced by erythropoietin and related molecules

  2018cites this paper
• Endothelin

  2016cites this paper
• Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin-1: exercise attenuated hypertension, oxidative stress, inflammation and immune response

  2014cites this paper
• The correlation between endothelin-1 levels and spirometry in dialysis patients compared to healthy subjects.

  2013cites this paper
• Endothelin antagonists for diabetic and non‐diabetic chronic kidney disease

  2012cites this paper
• Increased ET-1 and Reduced ETB Receptor Expression in Uremic Hypertensive Rats

  2010cites this paper
• Arterial stiffness and functional properties in chronic kidney disease patients on different dialysis modalities: an exploratory study.

  2010cites this paper
• Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.

  2009cites this paper
• Drug discovery for overcoming chronic kidney disease (CKD): the endothelin ET B receptor/nitric oxide system functions as a protective factor in CKD.

  2009cites this paper
• Exaggerated renal pathology of partial ablation-induced chronic renal failure in eNOS deficient mice.

  2008cites this paper
• Étude du rôle du TGF-ß1 dans la pathogenèse de l'hypertension artérielle et de l'insuffisance rénale

  2007cites this paper
• The Association of Social Status and Blood Pressure With Markers of Vascular Inflammation

  2006influential citation
• EFFET DE L'INHIBITION CHRONIQUE DE LA SYNTHÈSE DU MONOXYDE D'AZOTE SUR LA PRESSION ARTÉRIELLE ET L'APPARITION DES DOMMAGES CARDIOVASCULAIRES ET RÉNAUX CHEZ LE RAT HARLAN SPRAGUE-DAWLEY

  2005cites this paper
• Endothelin-1 Plasma Levels in Hemodialysis Treatment—The Influence of Type 2 Diabetes

  2005cites this paper
• ÉTUDE DE LA SUREXPRESSION IN VIVO DE LA MONOXYDE D'AZOTE SYNTHASE ENDOTHÉLIALE CHEZ LE RAT URÉMIQUE : EFFETS SUR LA DYSFONCTION ENDOTHÉLIALE EN INSUFFISANCE RÉNALE

  2005cites this paper
• Role of endothelin ETB receptor in partial ablation-induced chronic renal failure in rats.

  2004cites this paper
• Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats.

  2004cites this paper
• Effect of tibolone on markers of cardiovascular disease risk in postmenopausal women undergoing hemodialysis: a pilot study.

  2004cites this paper
• Plasma Endothelin-1 in Hemodialysis Treatment - the Influence of Hypertension

  2004cites this paper
• Endothelin-1 levels and cardiovascular risk factors in renal transplant patients.

  2004cites this paper
• Endothelin-1 in chronic renal failure and hypertension.

  2003cites this paper
• SURVEY REVIEW / SYNTHÈSE D'ENSEMBLE

  2003cites this paper
• Relationship between Eicosanoids and Endothelin-1 in the Pathogenesis of Erythropoietin-induced Hypertension in Uremic Rats

  2003cites this paper
• Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats

  2001cites this paper
• Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.

  2001cites this paper
• Influence of Recombinant Human Erythropoietin Therapy on Plasma Endothelin-1 Levels during Hemodialysis

  2001cites this paper
• Plasma endothelin-1 levels in hemodialysis patients with chronic cardiac failure

  2000cites this paper
• CHRONIC NITRIC OXIDE INHIBITION AGGRAVATES HYPERTENSION IN ERYTHROPOIETIN-TREATED RENAL FAILURE RATS

  2000cites this paper
• NORMALIZATION OF HEMATOCRIT IN HEMODIALYSIS PATIENTS WITH CARDIAC DISEASE DOES NOT INCREASE BLOOD PRESSURE

  2000cites this paper
• POLYMYXIN B-IMMOBILIZED FIBER REDUCES INCREASED PLASMA ENDOTHELIN-1 CONCENTRATIONS IN HEMODIALYSIS PATIENTS WITH SEPSIS

  2000cites this paper
• Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.

  1999cites this paper
• Endothelin and its antagonists in hypertension: Can we foresee the future?

  1999cites this paper
• Endothelin receptor antagonists: novel agents for the treatment of hypertension?

  1999cites this paper
• Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure.

  1999cites this paper
• Plasma and peritoneal endothelin levels and blood pressure in CAPD patients with or without erythropoietin replacement therapy.

  1998cites this paper
• Plasma and blood vessel endothelin-1 concentrations in hypertensive uremic rats treated with erythropoietin.

  1998cites this paper
• Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass.

  1998cites this paper
• Anemia and Its Treatment in Children on CAPD/CCPD

  1998cites this paper
• Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients.

  1998cites this paper
• The role of endothelin in hypertension

  1998cites this paper
• Endothelins in the normal and diseased kidney.

  1997cites this paper
• Uremia enhances the blood pressure response to erythropoietin.

  1997cites this paper
• Increased Endothelin-1 Mrna Expression in Peripheral Blood Monocytes of Dialysis Patients

  1997cites this paper
• Safety and efficacy of low-dose subcutaneous erythropoietin in hemodialysis patients.

  1997cites this paper
• Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass.

  1997cites this paper
• Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients.

  1996cites this paper
• Blood pressure control in chronic hemodialysis patients

  1996cites this paper
• Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients.

  1995cites this paper
• Epoetin Alfa

  1995cites this paper